We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Antisoma | LSE:ASM | London | Ordinary Share | GB0055696032 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.325 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
09/7/2012 19:09 | john smith - I wasnt referring to salaries | the_doctor | |
05/7/2012 14:13 | Hi the-doctor, Everyone except 4 directors have been fired in antisoma. Directors salaries have been slashed to 29000, 30000, 3000 and 1 unknown (new director Ross Hollyman). Therefore, money drain has stopped and should be covered from interest of money in the bank and remaining 1mil annual payments for the drug they previously sold off. They also have some large tax offset available to them due to previous R&D activity. All money will now be invested in to a range of smaller investments (probably non-pharmaceutical) rather than 1 or 2 high risk drugs (Avg. 70% failure rate per drug). The future looks bright, | johnsmith321 | |
05/7/2012 13:21 | After trading this a few times, I cant really see any point to this co. Like some others, it will IMO just fritter away the cash it has on some other gambles, while of course paying directors too much for not doing a lot. AKT on the other hand I think has a lot of potential and could see nice gains... | the_doctor | |
01/7/2012 18:43 | Another month passes with no news. | jsbach123 | |
19/6/2012 15:59 | 50p would be a nice price now. Another failed pharma to join the legion. | volsung | |
28/5/2012 22:19 | Another month passes with no news - though today has been 'enlivened' by a further slump in share price | jsbach123 | |
27/4/2012 06:55 | Another month passes with no news. | jsbach123 | |
26/3/2012 20:15 | Yes we have written it off (not just mentally) but for me it is similar to reading horoscopes in newspapers, one knows that they are rubbish but sometimes they raise a smile. | jsbach123 | |
26/3/2012 18:31 | I suppose the issue is we have all mentally written this one off. Presumably there are few shareholders left with any real value. Directors can take advantage of our apathy and milk it dry for themselves. | fenners66 | |
23/3/2012 16:46 | When are they going to make their first investment? Time is passing. There are many businesses crying out for funding allegedly - surely some of them are worth a punt? Meanwhile the cash trickles away. | twistedmelon | |
23/3/2012 12:39 | ditto - they proved themselves incapable of investing in stuff which worked when they were a 'real' company - why would it be expected that they'd be any better at it as a virtual one? Their only value is as a shell for someone to reverse into, but even then the likelihood of shareholders ever being able to sell for more than if the cash were just distributed now is very unlikely indeed. GIVE UP AND GIVE THE SHAREHOLDERS BACK THE CASH | filbert3 | |
11/1/2012 16:48 | Why don't they just give the remaining money back to shareholders? - Oh - I get it - to continue the ongoing gravy train at further continued shareholders expense. | filbert3 | |
07/12/2011 18:35 | In point of fact [with reference to post 5736 above] the current value of the shares broadly = the cash held, assuming cash of £12m. Investing that cash to make a return is of far more interest to me than selling for its current value. I rather hope it is NOT in pharma. | leedskier | |
23/11/2011 16:49 | incorrect doctor. Im not invested here, but will be shortly. | mrsapeslaptop | |
23/11/2011 11:38 | Sadly, this company just strikes me as pointless now The products they sold generated barely anything and it sounds as if there'll be no value remaining from those but royalties - which would be years away They should IMO close up and return cash to investors I'm not a shareholder here. The only people that'll make money will be the advisers that take their annual fees. | the_doctor | |
19/11/2011 19:24 | Deleted as I just read the news. | jsbach123 | |
08/11/2011 16:36 | doc. (not) You still hold shares in this? | freddie ferret | |
07/11/2011 17:46 | 'they must know something' they didnt know anything in the past | the_doctor | |
07/11/2011 17:41 | i think that filipe has got it right. | jsbach123 | |
03/11/2011 15:35 | they must know something otherwise why would they keep buying | davenic | |
03/11/2011 11:45 | The 10m plus trades this morning and 4m on monday may have taken ORA to over 28% | balcony | |
26/10/2011 14:58 | My guess is that the move to the AIM will coincide with a merger or suchlike with one of ORA's other investments. I've had ASM in the past and done ok with them....have just taken 75k shrs which doesn't show up on either Level 2 or Plus, on the strength of eventually something worthwhile coming up as a result of the ORA holding. gla f | fillipe |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions